Addus HomeCare Corporation (NASDAQ:ADUS – Get Free Report) CEO R Dirk Allison sold 4,988 shares of Addus HomeCare stock in a transaction dated Tuesday, February 24th. The stock was sold at an average price of $106.98, for a total value of $533,616.24. Following the completion of the transaction, the chief executive officer owned 185,514 shares in the company, valued at $19,846,287.72. The trade was a 2.62% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
R Dirk Allison also recently made the following trade(s):
- On Wednesday, February 25th, R Dirk Allison sold 2,364 shares of Addus HomeCare stock. The shares were sold at an average price of $105.36, for a total value of $249,071.04.
Addus HomeCare Stock Performance
ADUS opened at $103.53 on Friday. The company has a quick ratio of 1.66, a current ratio of 1.80 and a debt-to-equity ratio of 0.11. The stock’s 50 day moving average price is $109.22 and its two-hundred day moving average price is $112.95. The firm has a market capitalization of $1.92 billion, a P/E ratio of 19.87, a price-to-earnings-growth ratio of 1.44 and a beta of 0.91. Addus HomeCare Corporation has a 12-month low of $88.96 and a 12-month high of $124.43.
Addus HomeCare News Summary
- Positive Sentiment: Large institutional holders have been adding to positions in recent quarters, which provides a steady shareholder base and underlying demand. MarketBeat ADUS Institutional Holdings
- Positive Sentiment: Stephens kept an “Overweight” rating on ADUS and a $135 price target (trimmed from $140), signaling continued analyst conviction even after the cut. That backing can limit downside over the medium term. Stephens PT story
- Neutral Sentiment: Short‑interest figures are inconsistent across feeds (some reports show zero or NaN, others show a material rise). This data noise makes it hard to interpret immediate short pressure — confirm with FINRA/exchange data before acting. MarketBeat short interest
- Negative Sentiment: Significant insider selling across Feb. 24–25: CEO R. Dirk Allison and multiple EVPs sold several thousand shares in aggregate (CEO filings disclosed to the SEC). Large, concentrated insider sales are weighing on sentiment and likely contributed to today’s weakness. CEO SEC filing
- Negative Sentiment: Media flagged a “pessimistic forecast” narrative after Stephens trimmed its target, which can reinforce short‑term selling despite the retained Overweight rating. That coverage likely amplified intra‑day pressure. AmericanBankingNews piece
- Negative Sentiment: Smaller insider sales (e.g., EVP Cliff Blessing) were also reported; while individually minor, the wave of coordinated filings increases headline risk and may trigger mechanical selling. InsiderTrades alert
Analysts Set New Price Targets
A number of analysts have weighed in on the stock. BMO Capital Markets assumed coverage on shares of Addus HomeCare in a report on Thursday, November 13th. They issued a “market perform” rating and a $120.00 price target for the company. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Addus HomeCare in a research report on Wednesday, January 21st. TD Cowen reiterated a “buy” rating on shares of Addus HomeCare in a research note on Wednesday, November 5th. KeyCorp restated an “overweight” rating on shares of Addus HomeCare in a research note on Wednesday. Finally, Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $139.00 price target on shares of Addus HomeCare in a report on Wednesday. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $134.33.
Read Our Latest Stock Analysis on ADUS
Institutional Inflows and Outflows
Institutional investors have recently modified their holdings of the company. Royal Bank of Canada lifted its position in Addus HomeCare by 24.3% during the 1st quarter. Royal Bank of Canada now owns 6,899 shares of the company’s stock worth $682,000 after buying an additional 1,347 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of Addus HomeCare by 4.6% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 10,374 shares of the company’s stock worth $1,026,000 after acquiring an additional 459 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in shares of Addus HomeCare by 6.1% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 51,679 shares of the company’s stock worth $5,111,000 after purchasing an additional 2,952 shares in the last quarter. Jane Street Group LLC grew its stake in shares of Addus HomeCare by 387.6% during the first quarter. Jane Street Group LLC now owns 11,045 shares of the company’s stock valued at $1,092,000 after purchasing an additional 8,780 shares during the last quarter. Finally, Intech Investment Management LLC increased its holdings in shares of Addus HomeCare by 44.7% in the first quarter. Intech Investment Management LLC now owns 14,362 shares of the company’s stock valued at $1,420,000 after purchasing an additional 4,439 shares in the last quarter. Institutional investors own 95.35% of the company’s stock.
Addus HomeCare Company Profile
Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.
The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.
Further Reading
- Five stocks we like better than Addus HomeCare
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- Unlocked: Elon Musk’s Next Big IPO
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Read this or regret it forever
- Silver paying 20% dividend. Plus 68% share gains
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.
